Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    14.40
    0.60 (4.35%)
    At close: Aug 21, 2025, 3:59 PM
    14.45
    0.35%
    Pre-market: Aug 22, 2025, 08:00 AM EDT

    Crescent Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025
    Period Ending Jun 30, 2025
    Revenue
    		 153.3M
    Cost of Revenue
    		 4.83M
    Gross Profit
    		 148.47M
    Operating Income
    		 5.63M
    Interest Income
    		 97K
    Pretax Income
    		 13.77M
    Net Income
    		 21.08M
    Selling & General & Admin
    		 107.28M
    Research & Development
    		 28.65M
    Other Expenses
    		 972K
    Operating Expenses
    		 136.91M
    Interest Expense
    		 1.07M
    Selling & Marketing Expenses
    		 82.05M
    Cost & Expenses
    		 141.74M
    Income Tax Expense
    		 -7.31M
    Shares Outstanding (Basic)
    		 n/a
    Shares Outstanding (Diluted)
    		 n/a
    EPS (Basic)
    		 50.25
    EPS (Diluted)
    		 42.31
    EBITDA
    		 22.29M
    EBIT
    		 -20.72M
    Depreciation & Amortization
    		 9.51M

    Add to Watchlist